AMPS announces the release of the PMB-AMPS Holter database

New York, April 7th, 2016 


AMPS LLC announces the release of PMB-AMPS Holter database.

AMPS is proud to announce a joint project with Dr. Pierre Maison-Blanche with the aim of launching an annotated Holter recording database.

Dr. Pierre Maison-Blanche, a graduate from the University of Paris, received a degree in cardiology in 1986. During his time at the university he worked with Professor Philippe Coumel. Since then he has accumulated and annotated a vast amount of continuous ECG recordings and he has now decided to make this data available by means of a partnership with AMPS.

The database consists of, to date, over 2000 annotated and anonymized continuous ECG recordings that can be used by manufacturers and software development companies seeking to test the reliability of their equipment and algorithms before launching them on the market.
The data is (and will continue to be) constantly updated.

Fabio Badilini, PhD, FACC, Chief Scientist and AMPS founder commented: "The joint project between myself and Dr. Maison-Blanche has been fruitful in one form or another for over a quarter of a century and I am delighted that we have now formalized his partnership with AMPS". He added, "For AMPS and its customers it’s an important milestone as Dr. Maison-Blanche's database represents an invaluable resource".
Dr Pierre Maison-Blanche commented: "This database originated a long time ago from an idea to train and educate young cardiology fellows. Over time, it has grown to become a huge repository of clinically valuable recordings in standard clinical settings. In this era of patches worn for weeks and continuous ECG telemetry there is a need for improved analysis software which would benefit the management of patients affected by cardiac arrhythmia"

This database will allow to establish standard metrics of accuracy (sensitivity and specificity and ROC curves) on large and clinically oriented sets of data.

The major features of the PMB-AMPS database include:

o Recordings acquired using digital Holter recorders at 200 Hz with an amplitude resolution of 10 µV. The majority are 2-Leads recordings with an average recording length above 21h
o Recordings from patients referred for atrial arrhythmia management, including pre- and post-ablation recordings, with documented episodes of paroxysmal or permanent atrial fibrillation.
o Recordings from patients referred for the documentation of symptoms with a 24h recording within normal limits.
o Recordings from patients referred for the documentation of symptoms with a 24h recording showing a variety of cardiac arrhythmias such as atrial extrasystoles, ventricular extrasystoles, runs and episodes of atrio-ventricular block.

For all recordings, ECG beat detection and arrhythmia analysis is automatically carried out using commercial software. This is followed by a dedicated and detailed cardiologist review which ensures that in all cases, at least 59 minutes per hour are properly edited (i.e. on a beat-to-beat basis).

As of today, the database is available to all AMPS customers either in full or in specific subsets as required.

About AMPS LLC: AMPS LLC, based in New York, NY, is a leading edge software company providing software solutions used specifically by Clinical Research Organizations and Pharmaceutical corporations in the field of quantitative ECG analysis and blood pressure monitoring and is well known for the support given to the FDA for the establishment of the HL7 XML ECG standard and for providing FDA Officials with the renewed AMPS XMLFDA Viewer tool. The company’s website is www.amps-llc.com.

About Pierre Maison-Blanche: Dr. Maison-Blanche serves as a Consultant for the Assistance Publique des Hôpitaux de Paris, Hôpital Bichat, Cardiology Unit. He is a Fellow of the French Society of Cardiology. He is also an independent consultant to a number of ECG manufacturers, ECG central laboratories, and Pharmaceutical companies. He is a full Member of the Cardiac Safety Research Consortium (CSRC) which was launched in 2006 by the FDA in conjunction with Duke University in order to support research into the assessment of cardiac safety for medical products.

For more information, please contact:  

AMPS, llc
418 Central Park West
New York, NY, 10025
www.amps-llc.com
For a pricing proposition: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
For a technical question: This e-mail address is being protected from spambots. You need JavaScript enabled to view it